Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein

被引:121
|
作者
Daub, H
Blencke, S
Habenberger, P
Kurtenbach, A
Dennenmoser, J
Wissing, J
Ullrich, A
Cotten, M
机构
[1] Axxima Pharmaceut AG, D-82152 Martinsried, Germany
[2] Max Planck Inst Biochem, Dept Biol Mol, D-82152 Martinsried, Germany
[3] Tech Univ Braunschweig, Dept Biochem, D-38124 Braunschweig, Germany
关键词
D O I
10.1128/JVI.76.16.8124-8137.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Phosphorylation of hepatitis B virus (HBV) core protein has recently been shown to be a prerequisite for pregenomic RNA encapsidation into viral capsids, but the host cell kinases mediating this essential step of the HBV replication cycle have not been identified. We detected two kinases of 95 and 115 kDa in HuH-7 total cell lysates which interacted specifically with the HBV core protein and phosphorylated its arginine-rich C-terminal domain. The 95-kDa kinase was purified and characterized as SR protein-specific kinase I (SRPK1) by mass spectrometry. Based on this finding, the 115-kDa kinase could be identified as the related kinase SRPK2 by immunoblot analysis. In vitro, both SRPKs phosphorylated HBV core protein on the same serine residues which are found to be phosphorylated in vivo. Moreover, the major cellular HBV core kinase activity detected in the total cell lysate showed biochemical properties identical to those of SRPK1 and SRPK2, as examined by measuring binding to a panel of chromatography media. We also clearly demonstrate that neither the cyclin-dependent kinases Cdc2 and Cdk2 nor protein kinase C, previously implicated in HBV core protein phosphorylation, can account for the HBV core protein kinase activity. We conclude that both SRPK1 and SRPK2 are most likely the cellular protein kinases mediating HBV core protein phosphorylation during viral infection and therefore represent important host cell targets for therapeutic intervention in HBV infection.
引用
收藏
页码:8124 / 8137
页数:14
相关论文
共 50 条
  • [1] Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein
    Zheng, YY
    Fu, XD
    Ou, JHJ
    VIROLOGY, 2005, 342 (01) : 150 - 158
  • [2] SRPK1 and SRPK2: Potential Diagnostic Marker for Diffuse Large B-Cell Lymphoma
    Minoo, P.
    Fu, X-D
    Wang, H-Y
    LABORATORY INVESTIGATION, 2013, 93 : 348A - 348A
  • [3] SRPK1 and SRPK2: Potential Diagnostic Marker for Diffuse Large B-Cell Lymphoma
    Minoo, P.
    Fu, X-D
    Wang, H-Y
    MODERN PATHOLOGY, 2013, 26 : 348A - 348A
  • [4] Hepatitis B virus core protein phosphorylation: Identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure
    Heger-Stevic, Julia
    Zimmermann, Peter
    Lecoq, Lauriane
    Boettcher, Bettina
    Nassal, Michael
    PLOS PATHOGENS, 2018, 14 (12)
  • [5] SRPK1 and LBR protein kinases show identical substrate specificities
    Papoutsopoulou, S
    Nikolakaki, E
    Giannakouros, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (03) : 602 - 607
  • [6] THE SPLICING FACTORS SRSF1 AND SRSF2 AND THEIR REGULATORS, THE KINASES SRPK1 AND SRPK2, ARE OVEREXPRESSED IN NON SMALL CELL LUNG CARCINOMA
    Gout, Stephanie
    Brambilla, Elisabeth
    Brambilla, Christian
    Gazzeri, Sylvie
    Eymin, Beatrice
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S708 - S709
  • [7] Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes
    Wang, HY
    Arden, KC
    Bermingham, JR
    Viars, CS
    Lin, W
    Boyer, AD
    Fu, XD
    GENOMICS, 1999, 57 (02) : 310 - 315
  • [8] CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
    Prattapong, Pongphol
    Ngernsombat, Chawalit
    Aimjongjun, Sathid
    Janvilisri, Tavan
    CANCER REPORTS, 2020, 3 (02)
  • [9] SRPK1: A cisplatin sensitive protein expressed in retinoblastoma
    Krishnakumar, Subramanian
    Mohan, Adithi
    Kandalam, Mallikarjuna
    Ramkumar, Hema L.
    Venkatesan, Nalini
    Das, Radha R.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (02) : 402 - 406
  • [10] Overexpression of splicing factors SRSF1 and SRSF2 and their regulators, kinase SRPK1 and SRPK2 in bronchial NSCLC carcinomas
    Gout, Stephanie
    Brambilla, Elisabeth
    Gazzeri, Sylvie
    Eymin, Beatrice
    BULLETIN DU CANCER, 2011, 98 : S27 - S27